Revenue Breakdown
Composition ()
No data
Revenue Streams
GE Healthcare Technologies Inc (GEHC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Total Imaging, accounting for 45.7% of total sales, equivalent to $2.35B. Other significant revenue streams include Total Ultrasound and Total PDx. Understanding this composition is critical for investors evaluating how GEHC navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, GE Healthcare Technologies Inc maintains a gross margin of 38.67%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 13.51%, while the net margin is 9.02%. These profitability ratios, combined with a Return on Equity (ROE) of 24.21%, provide a clear picture of how effectively GEHC converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, GEHC competes directly with industry leaders such as RMD and MDLN. With a market capitalization of $36.27B, it holds a significant position in the sector. When comparing efficiency, GEHC's gross margin of 38.67% stands against RMD's 60.56% and MDLN's 23.87%. Such benchmarking helps identify whether GE Healthcare Technologies Inc is trading at a premium or discount relative to its financial performance.
